Ensitrelvir (S-217622) Intermediate CAS 1360105-53-8 Purity >98.0% COVID-19

Short Description:

Chemical Name: 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)- 

CAS: 1360105-53-8

Purity: >98.0% (HPLC) 

Intermediate of Ensitrelvir (S-217622), COVID-19

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Product Detail

Related Products

Product Tags


Chemical Properties:

Chemical Name 1,3,5-Triazine-2,4(1H,3H)-dione, 3-(1,1-dimethylethyl)-6-(ethylthio)-
Synonyms 3-tert-butyl-6-(ethylthio)-1,3,5-triazine-2,4(1H,3H)-dione
CAS Number 1360105-53-8
CAT Number RF-PI1504
Stock Status In Stock 
Molecular Formula C9H15N3O2S
Molecular Weight 229.3
Brand Ruifu Chemical


Item Specifications
Purity >98.0%
Loss on Drying <1.00%
Total Impurities <2.00%
Test Standard Enterprise Standard
Usage Intermediate of Ensitrelvir (S-217622), COVID-19

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.





3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride (CAS: 135206-76-7) is an intermediate of Ensitrelvir (S-217622). Ensitrelvir is an antiviral drug developed by Shionogi in partnership with Hokkaido University, which acts as an orally active 3C-like protease inhibitor for the treatment of COVID-19 infection. It is taken by mouth, and has been successfully tested against the recently emerged Omicron variant. It became the first Japanese domestic pill to treat COVID-19, third to be regulatorally approved in Japan; in February 2022.

  • Write your message here and send it to us